GenMark
The core features have stayed consistent as GenMark is "dedicated to the syndromic approach" and remains focused on infectious diseases, a Roche executive said.
At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.
Roche Diagnostics Q1 Sales Climb 50 Percent
The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year.
GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock
The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month.
Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.
Mar 15, 2021
Roche to Acquire GenMark Diagnostics for $1.8B
Feb 11, 2021